Circulation

Vol. 152, Issue 3 Issue 3 2025
12
Articles

Articles in this Issue

The Elusiveness of “Rest”: The Challenges of Assessing Resting Coronary Physiology

Thabo Mahendiran, Adriaan Wilgenhof, Bernard de Bruyne Jul 22, 2025 pp. 147-149 10.1161/circulationaha.125.074343

A Pause, A Block, A Path Restored: The Heart’s Hidden Choreography

Angkawipa Trongtorsak, Kenneth Ellenbogen, Ajay Pillai Jul 22, 2025 pp. 205-207 10.1161/circulationaha.125.074781

Optimizing Sedation Strategies for Catheter Ablation Procedures: Balancing Safety, Efficacy, and Practice Variations

Louise Y. Sun Jul 22, 2025 pp. 160-162 10.1161/circulationaha.125.075339

COOPERATIVE-PFA: A Three-Arm Randomized Controlled Trial

Veronika Sochorová, Veronika Kunštátová, Pavel Osmancik et al. Jul 22, 2025 pp. 150-159 10.1161/circulationaha.125.074427

BACKGROUND: Deep analgosedation (DAS) or general anesthesia is mandatory for pulsed-field ablation of atrial fibrillation. In contrast to DAS, general anesthesia (conventional or total int...

Stepwise Anatomical Approach to Ablation of Intramural Outflow Tract Ventricular Arrhythmias Guided by Septal Coronary Venous Mapping

Andres Enriquez, Haran Yogasundaram, Víctor Neira et al. Jul 22, 2025 pp. 163-171 10.1161/circulationaha.125.074175

BACKGROUND: The intramural site of origin is a major cause of ablation failure of ventricular arrhythmias, and the optimal strategy is unclear. This study investigated the efficacy of a st...

Mitochondrial Tumor Suppressor 1A Attenuates Myocardial Infarction Injury by Maintaining the Coupling Between Mitochondria and Endoplasmic Reticulum

Yingchao Gong, Xue Lu, Xingchen Wang et al. Jul 22, 2025 pp. 183-201 10.1161/circulationaha.124.069737

BACKGROUND: Pathological cardiac remodeling after myocardial infarction (MI) is a leading cause of heart failure and sudden death. The detailed mechanisms underlying the transition to hear...

Letter by Pasupathy et al Regarding Article, “Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial”

Sivabaskari Pasupathy, Rosanna Tavella, John F. Beltrame Jul 22, 2025 10.1161/circulationaha.124.073687

Letter by Zhao Regarding Article, “Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial”

Jian Zhao Jul 22, 2025 10.1161/circulationaha.124.073267

Safeguarding Biomedical Research Investments

Bradley S. Marino, Cheryl Pegus Jul 22, 2025 10.1161/circulationaha.125.075623

Personalized Approach May Improve Hypertrophic Cardiomyopathy Diagnosis

Bridget M. Kuehn Jul 22, 2025 pp. 202-204 10.1161/circulationaha.125.074663

Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human Atherosclerosis

Kai-Uwe Jarr, Kaylin C.A. Palm, Gerard Pasterkamp et al. Jul 22, 2025 pp. 208-211 10.1161/circulationaha.124.072676

Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial

Louise R.A. Olde Nordkamp, Jolien A. de Veld, Abdul Ghani et al. Jul 22, 2025 pp. 172-182 10.1161/circulationaha.125.074576

BACKGROUND: The PRAETORIAN trial (A Prospective, Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) investigated the efficacy and...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page